Randomized Controlled Trial of Low-Dose Aspirin in Reducing Pregnancy  Loss in Women with Antiphospholipid Syndrome

Neena jamil, Rashida Kousar,Fareeha Faryal. Aneeza Sikander,Wajiha, Sania Ali, Farah  Naz Tahir

Randomized Controlled Trial of Low-Dose Aspirin in Reducing Pregnancy Loss in Women with Antiphospholipid Syndrome

Authors

Neena jamil, Rashida Kousar,Fareeha Faryal. Aneeza Sikander,Wajiha, Sania Ali, Farah Naz Tahir

Keywords:

Antiphospholipid Syndrome, Low-Dose Aspirin, Recurrent Pregnancy Loss

Abstract

Antiphospholipid syndrome (APS) is a significant contributor to recurrent pregnancy loss (RPL),
primarily due to its prothrombotic effects. This randomized controlled trial aimed to evaluate the
efficacy of low-dose aspirin

References

Kablak-Ziembicka A, Przewlocki T. Clinical significance of carotid intima-media complex

and carotid plaque assessment by ultrasound for the prediction of adverse cardiovascular

events in primary and secondary care patients. J Clin Med. 2021;10(20):4628. DOI:

https://doi.org/10.3390/jcm10204628

Downloads

Published

2025-05-31

How to Cite

Neena jamil, Rashida Kousar,Fareeha Faryal. Aneeza Sikander,Wajiha, Sania Ali, Farah Naz Tahir. (2025). Randomized Controlled Trial of Low-Dose Aspirin in Reducing Pregnancy Loss in Women with Antiphospholipid Syndrome . International Journal of Pharmacy Research & Technology (IJPRT), 15(1), 1233–1240. Retrieved from https://www.ijprt.org/index.php/pub/article/view/565